Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiation

Oncology (Switzerland)

Volumn 83, Issue 5, 2012, Pages 300-304

  Taketa, Takashi ^a   Correa, Arlene M ^b   Suzuki, Akihiro ^a   Blum, Mariela A ^a   Chien, Pamela ^a   Lee, Jeffrey H ^b   Welsh, James ^b   Lin, Steven H ^b   Maru, Dipen M ^b   Erasmus, Jeremy J ^a   Bhutani, Manoop S ^b   Weston, Brian ^b   Rice, David C ^b   Vaporciyan, Ara A ^b   Hofstetter, Wayne L ^b   Swisher, Stephen G ^b   Ajani, Jaffer A ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Department of Gastroenterology Hepatology and Nutrition ^*  (United States)

Author keywords

Chemoradiation; Esophageal cancer; Outcomes; Surgery; Trimodality

Indexed keywords

CISPLATIN DERIVATIVE; FLUOROPYRIMIDINE;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; CHEMORADIOTHERAPY; ENDOSCOPIC BIOPSY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE; RECURRENCE FREE SURVIVAL; SALVAGE THERAPY; TREATMENT REFUSAL;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; ESOPHAGOSCOPY; FEMALE; GASTRECTOMY; GASTROSCOPY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SALVAGE THERAPY; STOMACH NEOPLASMS; TREATMENT REFUSAL;

EID: 84865856655     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000341353     Document Type: Article

References (9)

1. Siegel R, Ward E, Brawley O, et al: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61: 212-236.
2. Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
3. Stahl M, Stuschke M, Lehmann N, et al: Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005; 23: 2310-2317.
4. Ajani JA, Barthel JS, Bentrem DJ, et al: Esophageal and esophagogastric junction cancers. J Natl Compr Canc Netw 2011; 9: 830-887.
5. Bedenne L, Michel P, Bouche O, et al: Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 2007; 25: 1160-1168.
6. Suzuki A, Xiao L, Hayashi Y, et al: Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy. Cancer 2011; 117: 4823-4833.
7. Javeri H, Xiao L, Rohren E, et al: Influence of the baseline 18F-fluoro-2-deoxy-D-glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cancer undergoing chemoradiation. Cancer 2009; 115: 624-630.
8. van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, Busch OR, ten Kate FJ, Creemers GJ, Punt CJ, Plukker JT, Verheul HM, Spillenaar Bilgen EJ, van Dekken H, van der Sangen MJ, Rozema T, Biermann K, Beukema JC, Piet AH, van Rij CM, Reinders JG, Tilanus HW, van der Gaast A: Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012; 366: 2074-2084.
9. Cooper JS, Guo MD, Herskovic A, et al: Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. Jama 1999; 281: 1623-1627.